Oncology Information System Market Size Forecast to Reach USD 7.1 Billion by 2035, Driven by Rising Demand for Integrated Cancer Care Management - Transparency Market Research

Oncology Information System (OIS) Market Size and Outlook 2035

The global oncology information system (OIS) market was valued at US$ 3.3 Bn in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2035, reaching US$ 7.1 Bn by 2035. The market is expanding steadily as cancer care providers adopt advanced digital solutions to streamline patient data management, support clinical decision-making, improve care coordination, and enhance treatment outcomes.

The rising global cancer burden, increasing complexity of oncology treatments, and growing need for integrated data platforms are fueling the demand for OIS across hospitals, cancer centers, and imaging facilities.

👉 Do not miss the latest market intelligence. Get your sample report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18659

Market Overview

An Oncology Information System (OIS) is a specialized digital platform that centralizes and manages clinical, administrative, therapeutic, and diagnostic data for oncology patients. It supports comprehensive cancer care-from screening and diagnosis to treatment planning, radiation therapy, chemotherapy, and long-term follow-ups.

Increasing adoption of precision medicine, integration of genomic data, and rapid advancements in radiation therapy technologies are driving the need for robust, interoperable, and AI-enabled OIS solutions. Providers are leveraging these systems to enhance workflow efficiency, reduce manual errors, and improve delivery of multidisciplinary cancer care.

The transition toward value-based healthcare and the emphasis on real-time outcomes monitoring further support market expansion.

Market Description

OIS platforms combine electronic medical records, imaging systems, treatment planning tools, and analytics capabilities to support end-to-end oncology workflows. Modern systems integrate with PACS, EHRs, radiation therapy equipment, and chemotherapy management modules to offer a holistic view of patient journeys.

Key features include:
• Treatment planning & scheduling
• Oncology-specific EMR management
• Image-guided therapy data integration
• Chemotherapy regimen management
• Radiation dose tracking
• Genomic data integration
• Predictive analytics & AI-based clinical decision support

As cancer care becomes increasingly data-intensive, OIS solutions help clinicians personalize therapies, manage large patient volumes, and ensure compliance with regulatory reporting standards.

Analysis of Key Players in the OIS Market

Leading companies are enhancing their platforms with AI-driven analytics, cloud-based deployment, and improved interoperability with EHR and imaging systems. Strategic partnerships with oncology centers and radiotherapy system manufacturers are shaping the competitive landscape.

Prominent companies include:
• Varian Medical Systems
• Elekta
• Philips Healthcare
• Cerner
• Epic Systems Corporation
• McKesson
• Flatiron Health
• Siemens Healthineers
• ViewRay, Inc.
• Accuray Incorporated
• BrainLab
• Oracle (Cerner Corporation)
• RaySearch Laboratories

Each company is profiled based on technology strengths, oncology software capabilities, global footprint, and recent strategic developments.

👉 Discuss how OIS adoption will impact your oncology segment - Request Sample PDF @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18659

Key Developments in the Market

• In August 2021, Siemens Healthineers acquired Varian Medical Systems to create a unique, integrated portfolio of oncology information system workflows.

• In June 2021, Koninklijke Philips N.V. announced that it had partnered with Elekta to develop advanced, personalized cancer care through precision oncology information solutions.

Key Player Strategies

• Cloud-First Deployment: Offering scalable cloud-based OIS solutions for multi-site cancer networks.
• AI & Predictive Analytics: Supporting precision oncology, treatment optimization, and outcome prediction.
• Interoperability: Ensuring seamless integration with EHRs, PACS, radiotherapy equipment, and lab systems.
• Patient-Centric Workflows: Improving patient engagement through portals, mobile tools, and remote monitoring.
• Collaborative Ecosystems: Partnerships between software providers, cancer centers, and diagnostic companies to improve data integration.

Market Challenges

• High cost of OIS implementation and integration.
• Data privacy and cybersecurity concerns in cloud-based oncology systems.
• Limited IT infrastructure in low- and middle-income countries.
• Interoperability issues with legacy hospital systems.

Market Opportunities

• Rising demand for precision oncology and personalized treatment planning.
• Increasing use of AI and ML in cancer diagnostics and therapy decision support.
• Expansion of tele-oncology and remote monitoring platforms.
• Rapid upgrades in radiotherapy equipment requiring advanced OIS capabilities.
• Growing adoption of cloud-based enterprise oncology solutions.

Market Segmentations
By Solution Type

• Patient Information Systems
• Treatment Planning Systems
• Oncology EMR Platforms
• Decision Support Systems
• Image Management Solutions
• Others

By Application

• Medical Oncology
• Radiation Oncology
• Surgical Oncology
• Chemotherapy Management
• Palliative Care

By Deployment Model

• Cloud-Based
• On-Premise
• Hybrid

By End User

• Hospitals
• Oncology Treatment Centers
• Diagnostic & Imaging Centers
• Research Institutes
• Specialty Clinics

By Region

• North America: Dominates due to technological maturity and strong cancer care infrastructure.
• Europe: Growing adoption of integrated oncology platforms and RWE analytics.
• Asia-Pacific: Fastest growth driven by rising cancer incidences and healthcare digitalization.
• Latin America & MEA: Emerging opportunities with expansion of cancer care networks.

📈 Get the Complete Oncology Information System Market Report
👉 Inquire Now - https://www.transparencymarketresearch.com/checkout.php?rep_id=18659<ype=S

Why Buy This Report?

• Comprehensive coverage of oncology workflow digitization trends.
• Detailed segmentation across solutions, applications, deployment, and end users.
• Competitive analysis with strategic insights from top OIS vendors.
• Forecast intelligence to support investment and expansion strategies.
• Evaluation of AI, cloud, and real-world data advancements driving market growth.

Conclusion

The Oncology Information System (OIS) market is poised for steady growth as cancer care providers embrace digital transformation to improve clinical workflows and treatment outcomes. With rising global cancer prevalence and increasing demand for precision medicine, OIS platforms are becoming indispensable in oncology settings. Although challenges such as high implementation costs and data security concerns persist, continued innovation in cloud, AI, and integrated oncology platforms is paving the way for enhanced efficiency, personalized care, and better patient management across the cancer care continuum.

More Trending Research Reports-

• AI in Drug Discovery Market -
https://www.transparencymarketresearch.com/ai-in-drug-discovery-market.html

• Blood Testing Market - https://www.transparencymarketresearch.com/blood-testing-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.